Crescent Biopharma to Present at September Investor Conferences
Crescent Biopharma (Nasdaq: CBIO), a biotechnology company focused on cancer therapies, has announced its participation in two major healthcare investor conferences in September 2025.
The company will participate in a fireside chat at the Cantor Global Healthcare Conference on September 4, 2025, at 1:00 p.m. ET, and at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, at 5:35 p.m. ET. Both events will take place in New York.
Webcasts will be available on the company's investor relations website, with replays accessible for 90 days.
Crescent Biopharma (Nasdaq: CBIO), azienda biotecnologica specializzata in terapie oncologiche, ha comunicato la sua partecipazione a due importanti conferenze per investitori nel settore sanitario a settembre 2025.
L'azienda interverrà in un fireside chat al Cantor Global Healthcare Conference il 4 settembre 2025 alle 13:00 ET e al Morgan Stanley 23rd Annual Global Healthcare Conference l'8 settembre 2025 alle 17:35 ET. Entrambi gli eventi si terranno a New York.
I webcast saranno disponibili sul sito degli investor relations della società, con le registrazioni consultabili per 90 giorni.
Crescent Biopharma (Nasdaq: CBIO), una compañía biotecnológica centrada en terapias contra el cáncer, ha anunciado su participación en dos importantes conferencias para inversores del sector salud en septiembre de 2025.
La empresa participará en un fireside chat en el Cantor Global Healthcare Conference el 4 de septiembre de 2025 a la 1:00 p.m. ET y en el Morgan Stanley 23rd Annual Global Healthcare Conference el 8 de septiembre de 2025 a las 5:35 p.m. ET. Ambos eventos tendrán lugar en Nueva York.
Los webcasts estarán disponibles en la web de relaciones con inversores de la compañía, con repeticiones accesibles durante 90 días.
Crescent Biopharma (Nasdaq: CBIO)는 암 치료제 개발에 주력하는 생명공학 기업으로, 2025년 9월에 열리는 주요 헬스케어 투자자 컨퍼런스 두 곳에 참가한다고 발표했습니다.
회사는 2025년 9월 4일 오후 1:00(ET)에 열리는 Cantor Global Healthcare Conference의 파이어사이드 채트에 참여하며, 2025년 9월 8일 오후 5:35(ET)에 열리는 Morgan Stanley 23rd Annual Global Healthcare Conference에도 참석합니다. 두 행사는 모두 뉴욕에서 개최됩니다.
웹캐스트는 회사의 투자자 관계 웹사이트에서 제공되며, 다시보기는 90일 동안 이용할 수 있습니다.
Crescent Biopharma (Nasdaq: CBIO), une société de biotechnologie spécialisée dans les thérapies contre le cancer, a annoncé sa participation à deux grandes conférences pour investisseurs du secteur de la santé en septembre 2025.
L'entreprise prendra part à un fireside chat lors du Cantor Global Healthcare Conference le 4 septembre 2025 à 13h00 ET, et au Morgan Stanley 23rd Annual Global Healthcare Conference le 8 septembre 2025 à 17h35 ET. Les deux événements se tiendront à New York.
Les webcasts seront disponibles sur le site des relations investisseurs de la société, avec des rediffusions accessibles pendant 90 jours.
Crescent Biopharma (Nasdaq: CBIO), ein Biotechnologieunternehmen mit Schwerpunkt auf Krebsbehandlungen, hat seine Teilnahme an zwei wichtigen Healthcare-Investorenkonferenzen im September 2025 angekündigt.
Das Unternehmen wird an einem Fireside-Chat auf der Cantor Global Healthcare Conference am 4. September 2025 um 13:00 Uhr ET sowie auf der Morgan Stanley 23rd Annual Global Healthcare Conference am 8. September 2025 um 17:35 Uhr ET teilnehmen. Beide Veranstaltungen finden in New York statt.
Webcasts sind auf der Investor-Relations-Website des Unternehmens verfügbar; Abrufe werden für 90 Tage bereitgehalten.
- None.
- None.
WALTHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:
- Cantor Global Healthcare Conference 2025, fireside chat on Thursday, September 4, 2025, at 1:00 p.m. ET in New York.
- Morgan Stanley 23rd Annual Global Healthcare Conference, fireside chat on Monday, September 8, 2025, at 5:35 p.m. ET in New York.
A live webcast of each presentation will be available in the Investors section of the Company's website at https://investors.crescentbiopharma.com/news-events/events, and a replay will be accessible for 90 days.
About Crescent Biopharma
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates. By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
Contact
Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586
FAQ
When is Crescent Biopharma (CBIO) presenting at the Cantor Global Healthcare Conference 2025?
What time is Crescent Biopharma's presentation at the Morgan Stanley Healthcare Conference?
Where can I watch Crescent Biopharma's (CBIO) investor conference presentations?
Which investor conferences is Crescent Biopharma (CBIO) attending in September 2025?
